Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting

A-C Fougerousse; F Maccari; A Beauchet; J Parier; C Boulard; P-A Becherel; N Quiles-Tsimaratos; T Le Guyadec; D Thomas-Beaulieu; B Halioua; E Begon; M Bastien; J-L Perrot; V Pallure; P Bilan; M Steff; P Pfister; A Vermersch-Langlin; T Boyé; L Mery-Bossard; H Maillard; M Kemula; C Girard; C Poiraud; J-B Monfort; I Kupfer-Bessaguet; M Perrussel; D Lons-Danic; N Sultan; E Lorier; M Zeitoun; L Wagner; G Gabison; E Mahé; GEM Resopso

doi:10.1111/jdv.15804

Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e476-e478. doi: 10.1111/jdv.15804. Epub 2019 Jul 30.

Authors

A-C Fougerousse¹, F Maccari², A Beauchet³, J Parier², C Boulard⁴, P-A Becherel⁵, N Quiles-Tsimaratos⁶, T Le Guyadec⁷, D Thomas-Beaulieu⁸, B Halioua⁹, E Begon¹⁰, M Bastien¹¹, J-L Perrot¹², V Pallure¹³, P Bilan¹⁴, M Steff¹⁴, P Pfister⁹, A Vermersch-Langlin¹⁵, T Boyé¹⁶, L Mery-Bossard¹⁷, H Maillard¹⁸, M Kemula⁹, C Girard¹⁹, C Poiraud²⁰, J-B Monfort²¹, I Kupfer-Bessaguet²², M Perrussel²³, D Lons-Danic²⁴, N Sultan²⁵, E Lorier⁹, M Zeitoun²⁶, L Wagner⁹, G Gabison²⁷, E Mahé²⁸; GEM Resopso

Affiliations

¹ Dermatology Department, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France.
² Private Office, La Varenne Saint Hilaire, France.
³ Department of Public Health, Centre Hospitalier Universitaire Ambroise Paré, APHP & UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France.
⁴ Dermatology Department, Hôpital du Havre, Montivilliers, France.
⁵ Dermatology Department, Hôpital Privé d'Antony, Antony, France.
⁶ Dermatology Department, Hôpital Saint-Joseph, Marseille, France.
⁷ Dermatology Department, Hôpital d'Instruction des Armées Percy, Clamart, France.
⁸ Dermatology Department, Centre Hospitalier Intercommunal Poissy-Saint Germain en Laye, Poissy, France.
⁹ Private Office, Paris, France.
¹⁰ Dermatology Department, Hôpital René Dubos, Pontoise, France.
¹¹ Private Office, Joinville-le-Pont, France.
¹² Dermatology Department, Centre Hospitalier Universitaire, Saint Etienne, France.
¹³ Dermatology Department, Centre Hospitalier, Perpignan, France.
¹⁴ Dermatology Department, Centre Hospitalier Robert Ballanger, Aulnay-sous-Bois, France.
¹⁵ Dermatology Department, Centre Hospitalier, Valenciennes, France.
¹⁶ Dermatology Department, Hôpital d'Instruction des Armées Sainte Anne, Toulon, France.
¹⁷ Dermatology Department, Centre Hospitalier François Quesnay, Mantes la Jolie, France.
¹⁸ Dermatology Department, Centre Hospitalier, Le Mans, France.
¹⁹ Dermatology Department, Centre Hospitalier Universitaire Sainte Eloi, Montpellier, France.
²⁰ Dermatology Department, Centre Hospitalier, La Roche sur Yon, France.
²¹ Dermatology Department, Centre Hospitalier Universitaire Tenon, Paris, France.
²² Dermatology Department, Centre Hospitalier, Niort, France.
²³ Private Office, Auray, France.
²⁴ Dermatology Department, Hôpital Saint Joseph, Paris, France.
²⁵ Dermatology Department, Centre Hospitalier Gabriel Martin, Saint-Paul, France.
²⁶ Private Office, Antony, France.
²⁷ Private Office, Saint Maurice, France.
²⁸ Dermatology Department, Hôpital Victor Dupouy, Argenteuil, France.

PMID: 31310364
DOI: 10.1111/jdv.15804

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Adult
Aged
Clinical Decision-Making*
Cross-Sectional Studies
Dermatologic Agents / therapeutic use*
Female
Humans
Male
Methotrexate / therapeutic use*
Middle Aged
Psoriasis / drug therapy*
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Dermatologic Agents
Thalidomide
apremilast
Methotrexate